<The GUMM fraud continues its collapse while VPHM trends higher.>
You've got to be kidding! GUMM was down a measly 7/8 of a point on Friday on a day when the DJIA was down 295, the Nasdaq was down 137, and the S&P 500 was down 42. You call this a "collapse" LMFAO! There's very little similarity between VPHM and GUMM and it doesn't make much sense to compare them.
Here's how some of your favorite stocks performed last week:
ONE: -2 1/2 (-9.4%)
COST: -6 3/4 (-13.1%) good thing that it finished 3 points off the low!
GUMM: +1/8 (+0.6%)!
Shoud I infer from these facts that ONE and COST are perpetrating frauds?? Their stocks were down about 10% last week and GUMM was actually up! I think that it's more likely that Wexler is perpetrating the stock fraud. You tout your short position in stocks like VLNC, REFR, and GUMM much more than anyone who is long.
<Not surprising since VPHM's product - while it may not gain approval - is at least based on real science as opposed to quackery/Homeopathy.>
Again, Mr. Know-It-All-NOT: The interaction of zinc ions with the rhinovirus and ICAM-1 is SCIENCE. The FDA permits Zicam to be LABLED as homeopathic because its active ingredient is contained in the homeopathic pharmacopeia of the United States. If you don't understand the difference between SCIENCE and LABELING issues, it's no wonder that you stupidly shorted GUMM from 11 to 20 something and are well under water on your position despite the pull back from 35.
<The last earnings report was horrible and I'm certain that the next will be absolutely dismal.>
The last earnings report was "horrible" only in your warped mind. How was it "horrible"? Are you as certain that the next report will be "dismal" as you were that sales of Zicam would be "neglible"? You have NEVER been right about GUMM on any substantive issue. You are simply full of hot air and have been proven wrong time and time again and will be proven wrong in the future.
For the record, what would you consider "dismal" earnings for the first quarter? If you aren't willing to answer this, then you are just blowing hot air. Tell us what would be dismal so we will have something to compare the actual results to.
Here are some facts about Gum Tech's financials.
YTY quarterly sales comparisons higher eight consecutive quarters.
1997 vs. 1998
Q1: +52.5%
Q2: +107.7%
Q3: +0.1%
Q4: +41.1%
1998 vs. 1999
Q1: +121.6%
Q2: +58.2%
Q3: +76.4%
Q4: +432.9%
In the quarter that you characterize as "horrible", the company increased their sales 432.9% from the same period last year and 292% sequentially from the third quarter of 1999. They made 13 cents per share, the first profit in several years. How in the hell is this "horrible"?
Here are some more facts: Gum Tech will be debt free as of the March balance sheet. This means ZERO debt. Citadel is completely paid off and so is all their other debt. Of course, this excludes accounts payable that will be on the books as of March 00. In addition, the company is sitting on a wad of cash due to the exercise of options over the last few months and earnings in Q4 99 and Q1 00. My, how quickly Gum Tech's balance sheet obsoleted the arguments about the company's financial condition from the critics here. This is what can happen when a small company has success with products in markets that are huge compared to their size. It's only going to get better for Gum Tech shareholders.
You are fighting a losing battle with this stock. According to my estimate, sales will be up about 500% YTY in the March 00 quarter, and up about 70% sequentially from the fourth quarter 99. Only a fool would short a company that has nine consecutive quarters of rapidly rising sales, more new products on the way that have already been announced that will sustain the growth, and obvious profits that justify a much higher valuation. |
